Short review on most exciting advances in viral hepatitis diagnosis extracted from abstracts submitted to forthcoming AASLD event. The most prominent being role of HCV core antigen detection and quantification as new tool for detection and monitoring of viremic patient and as an more economical alternative to NAT or HCV RNA quantification. We also review abstracts about creation of novel web-based tool kits and APPs that encourage people to test and get linked to care.

Hepatitis E virus (HEV) causes self-limiting acute icteric hepatitis and has epidemiological and clinical characteristics similar to those of hepatitis A virus (HAV) infection. The virus has been responsible for major outbreaks of infection in many developing countries in Asia, Africa and Latin America, whilst in industrialised countries of the West it is acquired through zoonotic transmission from animal reservoirs. The infection is particularly serious during pregnancy, whilst progressive liver disease has been described in immunosuppressed individuals who have been transplanted or are HIV positive.